Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
33.24 USD | +1.05% | -4.78% | +73.89% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 423M |
---|---|---|---|---|---|
Net income 2024 * | -66M | Net income 2025 * | -74M | EV / Sales 2024 * | - |
Net cash position 2024 * | 327M | Net cash position 2025 * | 501M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-8.52
x | P/E ratio 2025 * |
-9.08
x | Employees | 91 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 86.65% |
Latest transcript on Neurogene Inc.
1 day | +1.05% | ||
1 week | -4.78% | ||
Current month | -2.26% | ||
1 month | -17.72% | ||
3 months | +7.74% | ||
Current year | +73.89% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-09 | 33.7 | +2.43% | 1 788 |
24-05-08 | 32.9 | -3.06% | 60,719 |
24-05-07 | 33.94 | +3.44% | 71,992 |
24-05-06 | 32.81 | -10.43% | 61,305 |
24-05-03 | 36.63 | +3.50% | 44,192 |
Delayed Quote Nasdaq, May 09, 2024 at 09:45 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+73.89% | 423M | |
+23.21% | 46.71B | |
+48.83% | 41.8B | |
-1.15% | 41.52B | |
-3.42% | 29.55B | |
+10.53% | 25.78B | |
-21.17% | 19.26B | |
+0.06% | 12.14B | |
-0.07% | 12.08B | |
+26.25% | 11.98B |
- Stock Market
- Equities
- NGNE Stock